MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehlert, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehlert, F. J.

The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium

FJ Ehlert

The muscarinic receptor-binding properties of a series of muscarinic drugs were compared with their effects on adenylate cyclase in membranes of the rabbit myocardium. When measured by competitive inhibition of [3H]-N-methylscopolamine binding, the competition curves of the various agonists were adequately described by the ternary complex model. This model assumes that the receptor can bind reversibly with a guanine nucleotide binding protein in the membrane and that the affinity of the agonist for the receptor-guanine nucleotide-binding protein complex is higher than that for the free receptor. A satisfactory fit of the ternary complex model to the data could only be achieved assuming that very little receptor is precoupled with the guanine nucleotide-binding protein in the absence of agonist. There was good agreement between the efficacy of each agonist as measured by inhibition of adenylate cyclase and the estimate of the positive cooperativity between the binding of the agonist receptor complex and the guanine nucleotide-binding protein. Guanosine 5'-triphosphate (0.1 mM) had no significant effect on the binding of [3H]N-methylscopolamine but caused an increase in the concentration of the various agonists required for half-maximal receptor occupancy. There was good correlation between efficacy as measured by inhibition of adenylate cyclase and the influence of guanosine 5'-triphosphate on binding properties.

Volume 28, Issue 5, pp. 410-421, 11/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
F. J. Ehlert and M. T. Griffin
Two-State Models and the Analysis of the Allosteric Effect of Gallamine at the M2 Muscarinic Receptor
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 1039 - 1060.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. A. Tran, M. Matsui, and F. J. Ehlert
Differential Coupling of Muscarinic M1, M2, and M3 Receptors to Phosphoinositide Hydrolysis in Urinary Bladder and Longitudinal Muscle of the Ileum of the Mouse
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. O. Grant and E. E. El-Fakahany
Persistent Binding and Functional Antagonism by Xanomeline at the Muscarinic M5 Receptor
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Avlani, L. T. May, P. M. Sexton, and A. Christopoulos
Application of a Kinetic Model to the Apparently Complex Behavior of Negative and Positive Allosteric Modulators of Muscarinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1062 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Christopoulos and T. Kenakin
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. R. Linden, M. J. Chell, E. E. El-Fakahany, and V. S. Seybold
Neurokinin3 Receptors Couple to the Activation of Neuronal Nitric-Oxide Synthase in Stably Transfected Chinese Hamster Ovary Cells
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 559 - 568.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura
The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy
Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. E. Selley, Q. Liu, and S. R. Childers
Signal Transduction Correlates of Mu Opioid Agonist Intrinsic Efficacy: Receptor-Stimulated [35S]GTPgamma S Binding in mMOR-CHO Cells and Rat Thalamus
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 496 - 505.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. A. Wreggett and J. W. Wells
Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors
J. Biol. Chem., September 22, 1995; 270(38): 22488 - 22499.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. K. Vogel, V. A. Mosser, D. A. Bulseco, and M. I. Schimerlik
Porcine m2 Muscarinic Acetylcholine Receptor-Effector Coupling in Chinese Hamster Ovary Cells
J. Biol. Chem., June 30, 1995; 270(26): 15485 - 15493.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A Ashkenazi, J. Winslow, E. Peralta, G. Peterson, M. Schimerlik, D. Capon, and J Ramachandran
An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover
Science, October 30, 1987; 238(4827): 672 - 675.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics